Concepts in PCI

By Ted E. Feldman, MD, FESC, FACC, FSCAI

Is It Time to Change the Guidelines for STEMI?

Sripal Bangalore, MD, discusses the results of his recent STEMI meta-analysis and makes the case for a possible change to the guidelines.

DAPT for DES

Deciding the optimal dual-antiplatelet therapy duration for each patient.

By Usman Baber, MD, MS, and Roxana Mehran, MD

Durable Versus Biodegradable Polymer Drug-Eluting Stents

An overview of outcomes and the impact on real-world clinical practice.

By Elvin Kedhi, MD, PhD

Techniques for Percutaneous Revascularization of Coronary CTOs

Necessary skillsets for a hybrid approach to CTO PCI.

By Craig A. Thompson, MD, MMSc, and David V. Daniels, MD

PCI Versus CABG for Left Main CAD

An assessment of current guidelines, evidence, and strategies.

By Prashant Kaul, MD, FACC, FSCAI, and James P. Zidar, MD, FACC, FSCAI

Appropriate Use Criteria Update

Assessing the appropriate use of PCI in your practice.

By Steven P. Marso, MD

Managing 30-Day Readmissions After PCI

Understanding the causes and identifying risk factors to prevent readmission.

By Gregory W. Yost, DO; James C. Blankenship, MD; and Peter B. Berger, MD

CoreValve Approval

Jeffrey J. Popma, MD, Co-Principal Investigator of the United States CoreValve pivotal trials discusses the recent approval of the CoreValve device and its impact on patients and practice.

PCI for an Occluded Saphenous Vein Graft

Treating a lesion with high thrombus burden in a saphenous vein graft using a self-expandable stent, distal protection, and thrombectomy.

By Wojciech Wojakowski, MD, PhD, FESC, and Wojciech Wanha, MD

The Sunshine Act Inevitably Rises

2014's key implementation dates and how physicians can be better prepared for them.

By Steven J. Cagnetta, Esq., and Steven K. Ladd

Innovations

A preview of today's new products.

An Interview With Jeffrey J. Popma, MD

Co-Principal Investigator of the United States CoreValve pivotal trials discusses the results of the CoreValve Extreme Risk study, device regulation in the US, and his role as Chair of the C3 Summit.